Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Exelixis
Company Monitoring Page for Exelixis
latest headlines for company on cafepharma
BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis
BioSpace
Fri, 01/12/24 - 09:40 am
Tags:
Bioinvent
,
Exelixis
,
immuno-oncology
Exelixis lays off 175 employees in refocus on ‘emerging pipeline’
Fierce Biotech
Mon, 01/8/24 - 11:39 am
Tags:
Exelixis
,
layoffs
Cabometyx study ends early after researchers see 'dramatic' benefits in neuroendocrine tumors, Exelixis says
Fierce Pharma
Thu, 08/24/23 - 08:37 pm
Tags:
Carbometyx
,
Exelixis
,
clinical trials
,
neuroendocrine tumors
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Tags:
Eli Lilly
,
Retevmo
,
thyroid cancer
,
medullary thyroid cancer
,
clinical trials
,
Exelixis
,
Capometyx
,
Sanofi
,
Caprelsa
Exelixis and Ipsen to seek approval for Cabometyx in prostate cancer
Clinical Trials Arena
Mon, 08/21/23 - 10:02 am
Tags:
Exelixis
,
Ipsen
,
Carbometyx
,
prostate cancer
Exelixis, Teva settle Cabometyx patent litigation with 2031 generic license
Fierce Pharma
Mon, 07/24/23 - 11:32 am
Tags:
Exelixis
,
Teva Pharmaceutical
,
patents
,
legal
,
Cabometyx
,
cancer
Exelixis Advances Board Refreshment Plan
Businesswire
Thu, 04/13/23 - 10:23 pm
Tags:
Exelixis
Roche, Exelixis Suffer Another Late-Stage Cancer Combo Failure
BioSpace
Fri, 03/3/23 - 12:01 pm
Tags:
Roche
,
Exelixis
,
renal cell carcinoma
,
Tecentriq
,
Cabometyx
,
clinical trials
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer
Fierce Pharma
Sun, 12/11/22 - 01:20 pm
Tags:
Roche
,
Tecentriq
,
Exelixis
,
Cabometyx
,
clinical trials
,
non small cell lung cancer
Exelixis drug fails PhIII lung cancer trial with Cabometyx and Tecentriq combo
Endpoints
Fri, 12/9/22 - 10:39 am
Tags:
Exelixis
,
Cabometyx
,
Tecentriq
,
metastatic non-small cell lung cancer
,
clinical trials
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent
BioSpace
Thu, 11/3/22 - 07:34 pm
Tags:
Exelixis
,
Catalent
,
antibody-drug conjugate
Exelixis trot out Opdivo-Yervoy-Cabometyx combo win in kidney cancer. Will FDA accept?
Fierce Pharma
Mon, 07/11/22 - 05:48 pm
Tags:
Exelixis
,
Cabometyx
,
kidney cancer
,
Opdivo
,
Yervoy
,
Bristol Myers Squibb
ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
Tags:
antibody-drug conjugate
,
Exelixis
,
Bioinvent
,
Oxford BioTherapeutics
,
Immunogen
Exelixis taps into cancer antibody discoverer out of Sweden
Endpoints
Thu, 06/16/22 - 10:28 am
Tags:
Exelixis
,
Bioinvent
,
cancer
,
Sweden
,
immuno-oncology
Exelixis throws in the towel on early-stage liver cancer after final readout shows OS flop
Endpoints
Tue, 03/15/22 - 10:39 am
Tags:
Exelixis
,
Cabometyx
,
liver cancer
,
clinical trials
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis
,
M&A
,
Roche
,
Sandoz
,
Aurinia Pharmaceuticals
,
Alnylam
,
Exelixis
,
Incyte
,
Eisai
,
Genmab
Exelixis pulls a surprise win in thyroid cancer just days ahead of final Cabometyx readout
Endpoints
Mon, 09/20/21 - 11:57 am
Tags:
ESMO
,
Exelixis
,
thyroid cancer
,
Cabometyx
ESMO: Exelixis lays out promising early Cabometyx combo data in prostate cancer, but key discrepancies persist
Fierce Pharma
Sat, 09/18/21 - 08:27 pm
Tags:
ESMO
,
Exelixis
,
Cabometyx
,
Roche
,
Tecentriq
,
clinical trials
,
prostate cancer
Exelixis stunned by death of Chief Medical Officer Schwab, sales lead Berndt
Fierce Biotech
Tue, 09/7/21 - 10:49 am
Tags:
Exelixis
,
executives
In surprising flop, Exelixis' Cabometyx combo with Roche's Tecentriq fails to extend life in liver cancer
Fierce Pharma
Mon, 06/28/21 - 10:50 am
Tags:
Exelixis
,
Cabometyx
,
liver cancer
,
Bayer
,
Nexavar
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.